Clinical Research Directory
Browse clinical research sites, groups, and studies.
Staccato Alprazolam Abuse Liability
Sponsor: Nova Pneuma Inc.
Summary
Compare the abuse liabilities of Staccato Alprazolam, oral immediate-release alprazolam, and Staccato Placebo.
Official title: Abuse Liability Study of Staccato® Alprazolam for Inhalation in Subjects With Histories of Sedative Abuse
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2008-01
Completion Date
2009-01
Last Updated
2026-04-22
Healthy Volunteers
Yes
Conditions
Interventions
Inhaled placebo + oral placebo
Inhaled Staccato placebo + oral placebo
Inhaled alprazolam 0.5 mg
Inhaled Staccato alprazolam 0.5 mg + oral placebo
Inhaled alprazolam 1 mg
Inhaled Staccato alprazolam 1 mg + oral placebo
Inhaled alprazolam 2 mg
Inhaled Staccato alprazolam 2 mg + oral placebo
Oral alprazolam 1 mg
Oral alprazolam 1 mg + Inhaled placebo
Oral alprazolam 2 mg
Oral alprazolam 2 mg + Inhaled placebo
Oral alprazolam 4 m
Oral alprazolam 4 mg + Inhaled placebo
Oral alprazolam 2 mg qualifying session
Qualifying session (2 mg oral alprazolam)
Oral placebo qualifying session
Qualifying control session (oral placebo)
Locations (1)
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States